NCT00305045 Treating Refractory Major Depressive Disorder With Repetitive Transcranial Magnetic Stimulation Status COMPLETED Phase NA
NCT00290914 Safety and Efficacy Study of Vilazodone and Discovering Genetic Markers Associated With Response in Patients With Major Depressive Disorder Status COMPLETED Phase PHASE2
NCT00289523 EEG Biomarkers for Predicting Response to Antidepressant Therapy Status COMPLETED Phase N/A
NCT00278941 Quetiapine Fumarate as Monotherapy in the Maintenance Treatment of Patients With Major Depressive Disorder Status COMPLETED Phase PHASE3
NCT00277823 Study Evaluating Desvenlafaxine Sustained-Release (DVS-SR) in Adult Outpatients With Major Depressive Disorder Status COMPLETED Phase PHASE3
NCT00265291 Antidepressant Treatment of Mexican-Americans: UCLA Pharmacogenetics and Pharmacogenomics Research Group Status COMPLETED Phase PHASE2
NCT00262665 Randomized, Placebo-controlled Trial of an AMPAkine in Major Depressive Disorder Status WITHDRAWN Phase PHASE2
NCT00252356 Efficacy and Safety of SR58611A in Patients With Major Depressive Disorder Status COMPLETED Phase PHASE3
NCT00252330 Efficacy and Safety of SR58611A in Patients With Major Depressive Disorder Status COMPLETED Phase PHASE3
NCT00242229 Study Evaluating DVS-233 SR in Elderly Outpatients With Major Depressive Disorder Status COMPLETED Phase NA
NCT00239954 Escitalopram Combination Comparison Study for Adult Patients With Major Depressive Disorder Status UNKNOWN Phase PHASE3
NCT00232700 Investigation of a Combination Treatment of Escitalopram and rTMS Status COMPLETED Phase NA
NCT00229398 Medical and Psychiatric Co-Morbidity Among Treatment Resistant Patients With Major Depression Disorder Status COMPLETED Phase N/A